SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
July 13, 2004
Date of Report
(Earliest Reported Event)
HI-TECH PHARMACAL CO., INC.
(Exact name of registrant as specified in its charter)
Commission File No. 0-20424
| Delaware | 11-2638720 | |
(State or other jurisdiction of incorporation) | (IRS Employer Identification No.) |
369 Bayview Avenue Amityville, NY | 11701 | |
| (Address of principal executive offices) | (Zip Code) |
(631) 789-8228
Registrant’s telephone number, including area code
(Former names or former address, if changed since last report)
ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
On July 13, 2004, Hi-Tech Pharmacal Co., Inc. issued a press release, dated July 13, 2004, announcing its financial results for the quarter and fiscal year ended April 30, 2004. The text of that press release is attached hereto as Exhibit 99.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: July 13, 2004 | HI-TECH PHARMACAL CO., INC. | |||
By: | /s/ David S. Seltzer | |||
David S. Seltzer | ||||
President and Chief Executive Officer | ||||
EXHIBIT INDEX
| NUMBER | DESCRIPTION | |
| 99 | Press Release issued by Hi-Tech Pharmacal Co., Inc. on July 13, 2004. |
